These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


450 related items for PubMed ID: 25501544

  • 1. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
    Padda RS, Gkouvatsos K, Guido M, Mui J, Vali H, Pantopoulos K.
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb 15; 308(4):G251-61. PubMed ID: 25501544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC, Crawford DH, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, Clouston AD, Anderson GJ, Fletcher LM.
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov 15; 301(5):G865-76. PubMed ID: 21817060
    [Abstract] [Full Text] [Related]

  • 4. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P, Wilkinson N, Constante M, Fillebeen C, Gkouvatsos K, Wagner J, Buffler M, Becker C, Schümann K, Santos MM, Pantopoulos K.
    J Mol Med (Berl); 2015 May 15; 93(5):489-98. PubMed ID: 25609138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
    Preziosi ME, Singh S, Valore EV, Jung G, Popovic B, Poddar M, Nagarajan S, Ganz T, Monga SP.
    J Hepatol; 2017 Aug 15; 67(2):360-369. PubMed ID: 28341391
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HJV and HFE Play Distinct Roles in Regulating Hepcidin.
    Wu Q, Wang H, An P, Tao Y, Deng J, Zhang Z, Shen Y, Chen C, Min J, Wang F.
    Antioxid Redox Signal; 2015 May 20; 22(15):1325-36. PubMed ID: 25608116
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
    Li DJ, Liu J, Hua X, Fu H, Huang F, Fei YB, Lu WJ, Shen FM, Wang P.
    Metabolism; 2018 Feb 20; 79():52-63. PubMed ID: 29129819
    [Abstract] [Full Text] [Related]

  • 15. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F.
    Clin Exp Pharmacol Physiol; 2013 Jul 20; 40(7):422-30. PubMed ID: 23611112
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload.
    Niederkofler V, Salie R, Arber S.
    J Clin Invest; 2005 Aug 20; 115(8):2180-6. PubMed ID: 16075058
    [Abstract] [Full Text] [Related]

  • 18. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA, Angulo P, Abraham SC, Torgerson H, Brandhagen D.
    Liver Int; 2006 Apr 20; 26(3):298-304. PubMed ID: 16584391
    [Abstract] [Full Text] [Related]

  • 19. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM.
    Hepatology; 2007 Jun 20; 45(6):1366-74. PubMed ID: 17476695
    [Abstract] [Full Text] [Related]

  • 20. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
    Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G.
    Am J Clin Nutr; 2008 May 20; 87(5):1374-83. PubMed ID: 18469261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.